Initiator Pharma: Outcome of Rights Issue Announced

Research Note

2022-07-05

13:30

Redeye leaves a comment following Initiator Pharma’s announcement of the outcome of the recent preferential rights issue.

KS

Kevin Sule

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.